BioMall
Brand Store/BDB Bioscience/BD HorizonTM BV421 Mouse Anti-Human IL-13 Receptor alpha2 (CD213a2)
B
GENERAL CATALOGUE

BD HorizonTM BV421 Mouse Anti-Human IL-13 Receptor alpha2 (CD213a2)

570032 · 100 Tests

BDB Bioscience · Cat: 570032

₹390 – ₹600 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 570032
Category: reagents
Pack Size: 100 Tests
Brand: BDB Bioscience

Description

Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570032/570113; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo Software. Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570032/570113; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo Software. Show More Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570032/570113; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo Software.

More from BDB Bioscience

B
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
B
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
B
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
B
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
B
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
B
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
B
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
B
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents